Den første reelle bjergetape i årets Giro d'Italia leverede endnu et bidrag til fornemmelsen af, at Tadej Pogacar bliver mere end almindeligt svær at fravriste sejren i løbet. På den ...
Selvom det nærmest virkede som om, at Tadej Pogacar tog sig en slapper på dagens ottende etape af Giro d'Italia, blev det til endnu en magtdemonstration fra den slovenske superstjerne, der var suveræn ...
Jonathan Milan var tæt på et vildt comeback, men Tim Merlier vandt 21. og sidste etape i Giroen. Tadej Pogacar er samlet vinder af Giro d'Italia 2024. Det blev en kendsgerning søndag, da UAE-stjernen ...
PERUGIA, ITALY - MAY 10: Tadej Pogacar of Slovenia and UAE Team Emirates - Pink Leader Jersey sprints while fans cheers during the 107th Giro d’Italia 2024, Stage 7 a 40,6km individual time trial ...
Maybe I would have been in trouble and lost a lot of time," said Pogacar. But that didn’t happen. "With my strong team and the pink jersey, it’s easier, so I have to thank the team for that.
May 4 (Reuters) - Jhonatan Narvaez of Ineos Grenadiers outsprinted Giro d'Italia favourite Tadej Pogacar to win Saturday's stage one 140-kilometre ride from Venaria Reale to Turin, with the ...
May 9 (Reuters) - Spain's Pelayo Sanchez claimed victory on stage six of the Giro d'Italia on Thursday as he out-sprinted two other breakaway riders at the uphill finish at Rapolano Terme.
There may well be one new member of the Giro d’Italia peloton annoyed with the dominant race leader. Tadej Pogacar said he was certain other riders were annoyed by his desire to win as many ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Tadej Pogacar angreb ikke, men sad bare med til mål på Prati di Tivo, hvor han var suveræn på målstregen. Den første reelle bjergetape i årets Giro d'Italia leverede endnu et bidrag til fornemmelsen ...
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the ...